Brian O Mahony/X
Nov 4, 2025, 09:17
HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, posted on X.
” The first of our HaemophiliaIRL series of 6 clinical webinars has just started.
This evenings topic: New Therapeutic Possibilities for von Willebrand Disease.
Speaker is Prof. David Lillicrap from Canada. All who registered will recieve a specific e -zine and link to recording.”
Stay updated with Hemostasis Today.
-
May 14, 2026, 05:19Tackling Cardiovascular Comorbidities in Bleeding Disorders – EHC
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk